JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Add like
Add dislike
Add to saved papers

Exercise during a 3-min decompression stop reduces postdive venous gas bubbles.

PURPOSE: Decompression sickness is initiated by the formation of gas bubbles in tissue and blood if the divers return to surface pressure too fast. The effect of exercise before, during, and after dive on bubble formation is still controversial. We have reported recently that strenuous aerobic exercise 24 h before simulated dive ameliorates venous bubble formation. The objective of this field study was to evaluate whether mild, continuous exercise during decompression has a similar impact.

METHODS: Ten healthy, military male divers performed an open-sea field dive to 30 m of sea water breathing air, remaining at pressure for 30 min. During the bottom and decompression the subjects performed fin underwater swimming at about 30% of maximal oxygen uptake. Each diver underwent two randomly assigned dives, one with and one without exercise during the 3-min decompression period. Monitoring of venous gas emboli was performed in the right heart with ultrasonic scanner every 20 min for 60 min after reaching surface pressure in supine rest and during forced two-cough procedure.

RESULTS: The study demonstrates that a mild, continuous exercise during decompression significantly reduced the average number of bubbles in the pulmonary artery from 0.9 +/- 0.8 to 0.3 +/- 0.5 bubbles per square centimeter in supine rest, as well as during two-cough procedure, which decreased from 4.6 +/- 4.5 to 0.9 +/- 0.9 bubbles per square centimeter. No symptoms of decompression sickness were observed in any subject.

CONCLUSION: These results, obtained in the field conditions, indicate that a mild, underwater swimming during a 3-min decompression period reduces postdive gas bubbles formation.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app